|
1
|
Klein A: Pancreatic cancer epidemiology:
Understanding the role of lifestyle and inherited risk factors. Nat
Rev Gastroenterol Hepatol. 18:493–502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Dosso S, Siebenhüner AR, Winder T,
Meisel A, Fritsch R, Astaras C, Szturz P and Borner M: Treatment
landscape of metastatic pancreatic cancer. Cancer Treat Rev.
96:1021802021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian Y, Gong Y, Fan Z, Luo G, Huang Q,
Deng S, Cheng H, Jin K, Ni Q, Yu X and Liu C: Molecular alterations
and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol
Oncol. 13:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
You A, Tian W, Yuan H, Gu L, Zhou J and
Deng D: TTC22 promotes m6A-mediated WTAP expression and colon
cancer metastasis in an RPL4 binding-dependent pattern. Oncogene.
41:3925–3938. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian W, Du Y, Ma Y, Zhang B, Gu L, Zhou J
and Deng D: miR663a-TTC22V1 axis inhibits colon cancer metastasis.
Oncol Rep. 41:1718–1728. 2019.PubMed/NCBI
|
|
7
|
Jin MZ and Jin WL: The updated landscape
of tumor microenvironment and drug repurposing. Signal Transduct
Target Ther. 5:1662020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Visser KE and Joyce JA: The evolving
tumor microenvironment: From cancer initiation to metastatic
outgrowth. Cancer Cell. 41:374–403. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pitt JM, Marabelle A, Eggermont A, Soria
JC, Kroemer G and Zitvogel L: Targeting the tumor microenvironment:
removing obstruction to anticancer immune responses and
immunotherapy. Ann Oncol. 27:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
R Core Team: R: A language and environment
for statistical computing. R Foundation for Statistical Computing;
Vienna, Austria: 2022
|
|
11
|
Fox J and Weisberg S: _An R Companion to
Applied Regression_,. Third edition. Sage; Thousand Oaks CA:
2019
|
|
12
|
Blanche P, Dartigues JF and Jacqmin-Gadda
H: Estimating and comparing time-dependent areas under receiver
operating characteristic curves for censored event times with
competing risks. Stat Med. 32:5381–5397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Robin X, Turck N, Hainard A, Tiberti N,
Lisacek F, Sanchez JC and Müller M: pROC: An open-source package
for R and S+ to analyze and compare ROC curves. BMC Bioinformatics.
12:772011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonneville R, Krook MA, Kautto EA, Miya J,
Wing MR, Chen HZ, Reeser JW, Yu L and Roychowdhury S: Landscape of
microsatellite instability across 39 cancer types. JCO Precis
Oncol. 2017:172017.PubMed/NCBI
|
|
15
|
Beroukhim R, Mermel CH, Porter D, Wei G,
Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J,
Urashima M, et al: The landscape of somatic copy-number alteration
across human cancers. Nature. 463:899–905. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mayakonda A, Lin DC, Assenov Y, Plass C
and Koeffler HP: Maftools: Efficient and comprehensive analysis of
somatic variants in cancer. Genome Res. 28:1747–1756. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu Z, Gu L, Eils R, Schlesner M and Brors
B: circlize Implements and enhances circular visualization in R.
Bioinformatics. 30:2811–2812. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z,
Feng T, Zhou L, Tang W, Zhan L, et al: clusterProfiler 4.0: A
universal enrichment tool for interpreting omics data. Innovation
(Camb). 2:1001412021.PubMed/NCBI
|
|
20
|
Walter W, Sánchez-Cabo F and Ricote M:
GOplot: An R package for visually combining expression data with
functional analysis. Bioinformatics. 31:2912–2915. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy
JA, et al: The immune landscape of cancer. Immunity.
48:812–830.e14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loveday BPT, Lipton L and Thomson BN:
Pancreatic cancer: An update on diagnosis and management. Aust J
Gen Pract. 48:826–831. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai J, Chen H, Lu M, Zhang Y, Lu B, You L,
Zhang T, Dai M and Zhao Y: Advances in the epidemiology of
pancreatic cancer: Trends, risk factors, screening, and prognosis.
Cancer Lett. 520:1–11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wood LD, Canto MI, Jaffee EM and Simeone
DM: Pancreatic cancer: Pathogenesis, screening, diagnosis, and
treatment. Gastroenterology. 163:386–402.e1. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chapa-González C, López K, Lomelí KM,
Roacho-Pérez JA and Stevens JC: A review on the efficacy and safety
of Nab-paclitaxel with gemcitabine in combination with other
therapeutic agents as new treatment strategies in pancreatic
cancer. Life (Basel). 12:3272022.PubMed/NCBI
|
|
29
|
Xia T, Wu X, Cao M, Zhang P, Shi G, Zhang
J, Lu Z, Wu P, Cai B, Miao Y and Jiang K: The RNA m6A
methyltransferase METTL3 promotes pancreatic cancer cell
proliferation and invasion. Pathol Res Pract. 215:1526662019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lei Y, Yu T, Li C, Li J, Liang Y and Wang
X, Chen Y and Wang X: Expression of CAMK1 and its association with
clinicopathologic characteristics in pancreatic cancer. J Cell Mol
Med. 25:1198–1206. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Graham JB, Canniff NP and Hebert DN:
TPR-containing proteins control protein organization and
homeostasis for the endoplasmic reticulum. Crit Rev Biochem Mol
Biol. 54:103–118. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen M, Long Q, Borrie MS, Sun H, Zhang C,
Yang H, Shi D, Gartenberg MR and Deng W: Nucleoporin TPR promotes
tRNA nuclear export and protein synthesis in lung cancer cells.
PLoS Genet. 17:e10098992021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nie R, Liu Q and Wang X: TRPV1 Is a
potential tumor suppressor for its negative association with tumor
proliferation and positive association with antitumor immune
responses in pan-Cancer. J Oncol. 2022:69645502022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu X, Li N, Wang Y, Yu J and Mi J: Calcium
channel TRPV6 promotes breast cancer metastasis by NFATC2IP. Cancer
Lett. 519:150–160. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schizas D, Charalampakis N, Kole C,
Economopoulou P, Koustas E, Gkotsis E, Ziogas D, Psyrri A and
Karamouzis MV: Immunotherapy for pancreatic cancer: A 2020 update.
Cancer Treat Rev. 86:1020162020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bear AS, Vonderheide RH and O'Hara MH:
Challenges and opportunities for pancreatic cancer immunotherapy.
Cancer Cell. 38:788–802. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Balan S, Saxena M and Bhardwaj N:
Dendritic cell subsets and locations. Int Rev Cell Mol Biol.
348:1–68. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee YS and Radford KJ: The role of
dendritic cells in cancer. Int Rev Cell Mol Biol. 348:123–178.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gardner A, de Mingo Pulido Á and Ruffell
B: Dendritic cells and their role in immunotherapy. Fron Immunol.
11:9242020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang S, Wu Q, Chen T, Su R, Pan C, Qian J,
Huang H, Yin S, Xie H, Zhou L and Zheng S: Blocking CD47 promotes
antitumour immunity through CD103 dendritic cell-NK cell axis in
murine hepatocellular carcinoma model. J Hepatol. 77:467–478. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hegde S, Krisnawan VE, Herzog BH, Zuo C,
Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, et al:
Dendritic cell paucity leads to dysfunctional immune surveillance
in pancreatic cancer. Cancer Cell. 37:289–307.e9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lüönd F, Sugiyama N, Bill R, Bornes L,
Hager C, Tang F, Santacroce N, Beisel C, Ivanek R, Bürglin T, et
al: Distinct contributions of partial and full EMT to breast cancer
malignancy. Dev Cell. 56:3203–3221.e11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li S, Cong X, Gao H, Lan X, Li Z, Wang W,
Song S, Wang Y, Li C, Zhang H, et al: Tumor-associated neutrophils
induce EMT by IL-17a to promote migration and invasion in gastric
cancer cells. J Exp Clin Cancer Res. 38:62019. View Article : Google Scholar : PubMed/NCBI
|
